ENBREL 25 MG/ML PEDIA FL + SRG + NEC
(Etanercept) - Maladie rare sans désignation orpheline
*Treatment of polyarthritis (rheumatoid-factorpositive or -negative) and extended oligoarthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.
*Treatment of psoriatic arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, methotrexate.
*Treatment of enthesitis-related arthritis in adolescents from the age of 12 years who have had an inadequate response to, or who have proved intolerant of, conventional therapy.
Enbrel has not been studied in children aged less than 2 years.